718 filings
Page 11 of 36
4
CTSO
Cytosorbents Corp
20 Aug 20
Cytosorbents / Edward Raymond Jones ownership change
4:10pm
8-K
CTSO
Cytosorbents Corp
4 Aug 20
CytoSorbents Reports Record Second Quarter 2020 Financial Results
5:01pm
4
Kathleen P. Bloch
4 Aug 20
Cytosorbents / KATHLEEN P. BLOCH ownership change
4:31pm
10-Q
2020 Q2
CTSO
Cytosorbents Corp
Quarterly report
4 Aug 20
4:13pm
8-K
CTSO
Cytosorbents Corp
24 Jul 20
Other Events
4:08pm
424B5
CTSO
Cytosorbents Corp
22 Jul 20
Prospectus supplement for primary offering
5:26pm
8-K
CTSO
Cytosorbents Corp
22 Jul 20
CytoSorbents Corporation Announces Pricing of $50 Million Public Offering of Common Stock
5:26pm
FWP
CTSO
Cytosorbents Corp
21 Jul 20
Free writing prospectus
9:30pm
8-K
CTSO
Cytosorbents Corp
21 Jul 20
Other Events
9:30pm
424B5
CTSO
Cytosorbents Corp
20 Jul 20
Prospectus supplement for primary offering
5:25pm
8-K
CTSO
Cytosorbents Corp
20 Jul 20
CytoSorbents Provides Preliminary Q2 2020 Financial Results and Corporate Update
4:49pm
8-K
CTSO
Cytosorbents Corp
26 Jun 20
Other Events
12:00am
8-K
CTSO
Cytosorbents Corp
11 Jun 20
CytoSorbents Awarded $2,897,172 Phase III STTR Contract to Advance HemoDefend-BGA Plasma and Whole Blood Filter to Clinical Trials
4:30pm
8-K
CTSO
Cytosorbents Corp
4 Jun 20
Submission of Matters to a Vote of Security Holders
12:00am
8-K
CTSO
Cytosorbents Corp
12 May 20
CytoSorb® is E.U. Approved to Remove Rivaroxaban, a Leading Factor Xa Inhibitor and Novel Oral Anticoagulant, During On-Pump Cardiothoracic Surgery
4:30pm
4
Vincent Capponi
7 May 20
Cytosorbents / Vincent Capponi ownership change
6:01pm
4
CTSO
Cytosorbents Corp
7 May 20
Cytosorbents / Phillip P. Chan ownership change
6:00pm
8-K
CTSO
Cytosorbents Corp
5 May 20
CytoSorbents Reports First Quarter 2020 Financial and Operational Results
5:05pm
4
CTSO
Cytosorbents Corp
5 May 20
Cytosorbents / Efthymios Deliargyris ownership change
4:16pm
3
CTSO
Cytosorbents Corp
5 May 20
Cytosorbents / Efthymios Deliargyris ownership change
4:15pm